News
Vinay Prasad returns to the FDA, weeks after his ouster
WASHINGTON — Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine, gene therapy, and blood product regulation. “At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,” Health and Human Services spokesperson Andrew Nixon told STAT on Saturday.
Vinay Prasad, in surprise reversal, to rejoin FDA after abrupt departure
Less than weeks after stepping down, Prasad will return to lead CBER “at the FDA’s request,” according to an HHS spokesperson, marking the latest twist in an unusual run leading the FDA office overseeing vaccines and gene therapy.
Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At ...
After exiting the FDA less than two weeks ago for unclear reasons, Vinay Prasad is once again director of the Center for ...
Vinay Prasad, a top regulator at the US Food and Drug Administration, has left the agency after a controversy over his ...
Sarepta Therapeutics (SRPT) stock in focus as report says company hired a Trump-linked lobbying firm after deaths linked to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results